Factor structure of the Positive and Negative Syndrome Scale (PANSS) in Brazil: convergent validation of the Brazilian version by Higuchi, Cinthia Hiroko et al.
BRIEF COMMUNICATION
Factor structure of the Positive and Negative Syndrome
Scale (PANSS) in Brazil: convergent validation of the
Brazilian version
Cinthia H. Higuchi,1,2 Bruno Ortiz,1,2 Arthur A. Berberian,1,2 Cristiano Noto,1,2 Quirino Cordeiro,3
Sintia I. Belangero,1,5 Jose C. Pitta,4 Ary Gadelha,1,2 Rodrigo A. Bressan1,2
1Interdisciplinary Laboratory in Clinical Neuroscience (LiNC), Department of Psychiatry, Universidade Federal de Sa˜o Paulo (UNIFESP), Sa˜o
Paulo, SP, Brazil. 2Schizophrenia Program (PROESQ), UNIFESP, Sa˜o Paulo, SP, Brazil. 3Center for Integrated Mental Health, Faculdade de
Cieˆncias Me´dicas da Santa Casa de Sa˜o Paulo, Sa˜o Paulo, SP, Brazil. 4Department of Psychiatry, UNIFESP, Sa˜o Paulo, SP, Brazil.
5Genetics Division, Department of Morphology and Genetics, UNIFESP, Sa˜o Paulo, SP, Brazil.
Objectives: The Positive and Negative Syndrome Scale (PANSS) was developed to assess the
symptoms of schizophrenia dimensionally. Although it is widely used in clinical trials in Brazil, it is not
fully validated. The aim of this study is to assess the factor structure of the Brazilian PANSS and
generate validation data for its current version.
Methods: A total of 292 patients diagnosed with schizophrenia were enrolled.
Results: Principal component analysis suggested a forced five-factor final model that accounted for
58.44% of the total variance, composed of negative, disorganization/cognition, excitement, positive,
and depression/anxiety.
Conclusion: The Brazilian PANSS has a similar factor structure and internal consistency compared
to versions in several other languages.
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Introduction
Schizophrenia is a heterogeneous disorder with a wide
range of symptoms. This extensive clinical variability
poses a challenge for establishing accurate diagnosis
and assessing treatment response. The Positive and
Negative Syndrome Scale (PANSS) is one of the most
widely used instruments to evaluate psychotic symptoms.
It is composed of 30 items divided into three subscales –
Positive Symptoms, Negative Symptoms, and General
Psychopathology – developed to assess the severity of
symptoms and measure general psychopathology and
drug-related changes.1
The PANSS has become an important instrument
in schizophrenia research. It is one of the instruments
most frequently used to assess efficacy of antipsychotic
drugs, based on variation of its total score over time.2
It has been validated in several languages and used in
the majority of the studies of new drugs for schizo-
phrenia.
The PANSS Study Group successfully validated a
model composed by five dimensions.3 This five-factor
model was the most replicated model across studies in
the last decade.4
For use in Brazil, PANSS was translated into Brazilian
Portuguese by means of a standard cross-cultural
adaptation process, and its inter-rater reliability was
evaluated.5,6 Although the PANSS has been widely used
in the country, there have been no formal studies
validating the scale.
The aim of this study was to investigate whether the
factor structure of the Brazilian version of the PANSS
converges with the original version and with versions
validated for use in other countries/populations, and thus,
to generate validity data for the scale in Brazil.
Methods
The sample comprised 292 individuals with a diagnosis of
schizophrenia recruited from three different centers: 156
outpatients from the Schizophrenia Program (PROESQ)
at Universidade Federal de Sa˜o Paulo (UNIFESP), Brazil;
93 patients recently discharged from Hospital Luzia de
Pinho Melo; and 43 first-episode patients from Santa
Casa de Miserico´rdia de Sa˜o Paulo, Brazil.
The inclusion criteria were a diagnosis of schizophre-
nia, as defined by the DSM-IV; age between 12 and 65
years; and absence of severe intellectual disability
assessed by family report.
Overall, 191 participants (65.4% of the sample) were
men, and the mean 6 SD age was 33.64611.07 years
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(range, 15-63 years). The mean age at illness onset
was 23.1067.43 years (range, 12-54 years) and mean
duration of illness was 10.7069.67 years (range, 0-43
years). All patients were receiving antipsychotics. The
mean Global Assessment of Functioning score was
51.82614.28, and most of the subjects were ‘‘moderately
ill’’ (39.7%) according to the Clinical Global Impression
Severity scale (3.5761.12).
Modules A, B, C, D and E of the Structured Clinical
Interview for DSM-IV Axis I Disorders were used for
diagnosis and the PANSS was administered to assess
psychopathology. Eight experienced psychiatrists were
trained in both instruments through regular meetings and
clinical supervision.
The factor structure of the PANSS was fitted in a six-
factor model by principal component analysis (PCA), with
eigenvalues higher than one being retained for factor
extraction. Equamax rotation was used as in previous
studies with PANSS.7,8 Factor loadings of 0.5 or higher
were considered in the interpretation of the factors. The
internal consistency of each factor was determined by
Cronbach’s alpha.
Results
The mean6 SD (range) scores obtained were as follows:
total PANSS, 64.30617.37 (31-124); Positive subs-
cale, 13.5964.70 (7-33); Negative subscale, 18.4966.33
(7-43); and General Psychopathology, 32.1969.37 (16-76).
The PCA suggested six factors by the eigenvalue-one
criterion. Five of these explained most of the variance and
had acceptable internal consistency (. 0.70). The motor
factor presented a Cronbach’s alpha of 0.404 and
explained a small proportion of the variance, suggesting
factor inconsistence. Results of the rotated principal
component matrix with five and six factor loadings
accounted for 58.44 and 61.99% of the total variance,
respectively (Table 1).
Regarding sampling adequacy, the Kaiser-Meyer-Olkin
test value of 0.873 and the Bartlett test (chi-square =
4339.882, p , 0.001) indicated that the data were highly
suitable for factor extraction.
The items ‘‘preoccupation’’ (G15) and ‘‘active social
avoidance’’ (G16) were not related to any particular factor
in the six-factor model. These items, together with ‘‘somatic
concerns’’ (G1) and ‘‘lack of judgment and insight’’ (G12),
had insignificant values in the five-factor model.
Discussion
We evaluated the factor structure of the Brazilian version of
the PANSS and found a five-factor model similar to those
previously described in the literature: positive, negative,
disorganization/cognition, excitement and depression/
anxiety.
Some previous studies found different number of
factors. In the first factor structure study of the PANSS,
Kay & Sevy9 found four factors (negative, positive,
excited, and depressive) in an American population.
Most recent studies found five to seven factors.10-12 Our
model accounted for 58.44% of the total variance; this is
very similar to previous results, which ranged from 53.4 to
59.83%.7,10 As in other studies, the internal consistency
we obtained was good (. 0.8) for the negative and
disorganized factors, and acceptable (. 0.7) for the
remaining factors.10,13
Regarding the composition of individual factors, the
negative factor accounted for the greatest individual
contribution to variance in the final model (27.97%).7
The second most robust factor was the ‘‘disorganization/
cognitive’’ (11.75%). The item ‘‘Mannerisms’’ appeared
previously in the motor dimension of the six-factor model.
However, this item fit better when it was moved to the
disorganization/cognitive factor in the final five-factor
forced model. Fresan et al.7 highlighted this interface
between cognitive and motor components, with the item
‘‘Mannerisms’’ having the highest loading in the Cognitive
factor.
The Excitement factor was composed of the same
items noted in the study performed by Wallwork et al.4 of
a consensus factor structure of the PANSS. The positive,
depression/anxiety, and disorganization/cognition factors
were similar to previous studies.7,8,10,12,13
Regarding the sixth factor found and not included in the
final model, Emsley et al.10 performed a study of the
PANSS factor structure in recent-onset psychosis. They
suggested that the five-factor model did not suffice to
show the structure of the PANSS, because a seven-factor
model emerged in the exploratory phase of their study
with a last factor named ‘‘motor.’’ We found similar results
in our model, and a possible explanation for this might be
the presence in our sample of some first-episode patients
(14.72%), who can be more susceptible to the effect
of antipsychotics.14 Pappa & Dazzan,15 in a systematic
review, alternatively suggested that, although dyskinesia
and Parkinsonism can be induced by antipsychotics, in
drug-naı¨ve individuals they could also be the result of
neurologic dysfunction related to the pathogenesis under-
lying the illness. Either way, first-episode patients could
be more vulnerable to motor symptoms, which may have
biased previous studies.
Some PANSS items were not related to any factor.
The item ‘‘preoccupation’’ (G15) has some limitation in
clinical use, because it aims to assess autistic, ego-
centric concerns; however, it can be understood as
anxiety- or depression-related concern. ‘‘Active social
avoidance’’ (G16) is frequently on the negative factor,4
but was not related to any factor in our study. The item
‘‘somatic concern’’ (G1) was related to the motor factor
in our six-factor model; however, it could not be
considered a good discriminant item, as it is normally
correlated with the depression factor, in most of the
articles found in the literature.4 These items might
require revisiting to remain in the scale, because they
may not be useful for clinical practice or even for
research purposes. This does not seem to be a problem
specific to the Brazilian version, but rather an issue with
the PANSS itself.
Finally, these results should be interpreted in light of
some limitations. Although several methods could be
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used, we chose factor analysis (based on PCA method)
because it was the most widely used technique for
analysis of the factor structure of PANSS in previous
studies, allowing us to compare our findings to those
obtained in other countries/populations and generate
convergent validation. Our sample was composed of
individuals recruited from three different centers, from
all stages of the disorder, under various antipsychotic
treatment regimens, and assessed by different psychia-
trists, which resembles the clinical reality of schizophrenic
patients and reinforces the strength and validity of the
current Brazilian version.
The final five-factor model of the Brazilian version of
the PANSS presented a performance very similar to the
original English version and to those in several other
languages, suggesting convergent validity. PANSS is
one of the most important primary outcome measures
used to evaluate treatment efficacy in psychiatry, and
this study shows, for the first time, that its Brazilian
version is valid.
Acknowledgements
This work was supported by Fundac¸a˜o de Amparo a`
Pesquisa do Estado de Sa˜o Paulo/Conselho Nacional
de Desenvolvimento Cientı´fico e Tecnolo´gico (FAPESP/
CNPq - process: 2011/50740-5) and Coordenac¸a˜o de
Aperfeic¸oamento de Pessoal de Nı´vel Superior (CAPES).
RAB has received research grants from FAPESP, CNPq,
CAPES, Fundac¸a˜o Safra, and Fundac¸a˜o ABADS.
Disclosure
CN has served as a consultant and has been part of the
advisory board for Janssen-Cilag. AG has received
speaker’s honoraria and has served as a consultant for
Janssen-Cilag. RAB has received research grants from
Janssen-Cilag, Eli Lilly, Novartis, and Roche; has received
lecture fees from Astra Zeneca, Janssen, Novartis, and
Lundbeck; and is a shareholder of Radiopharmacus Ltda.
and Biomolecular Technology Ltda. The other authors
report no conflicts of interest.
References
1 Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome
scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-76.
2 Kinon BJ, Chen L, Ascher-Svanum H, Stauffer VL, Kollack-Walker S,
Sniadecki JL, et al. Predicting response to atypical antipsy-
chotics based on early response in the treatment of schizophrenia.
Schizophrenia Res. 2008;102:230-40.
3 White L, Harvey PD, Opler L, Lindenmayer JP. Empirical assess-
ment of the factorial structure of clinical symptoms in schizophrenia.
A multisite, multimodel evaluation of the factorial structure of the
Positive and Negative Syndrome Scale. The PANSS Study Group.
Psychopathology. 1997;30:263-74.
4 Wallwork RS, Fortgang R, Hashimoto R, Weinberger DR, Dickinson
D. Searching for a consensus five-factor model of the Positive and
Negative Syndrome Scale for schizophrenia. Schizophr Res. 2012;
137:246-50.
5 Chaves AC, Shirakawa I. Escala das sı´ndromes negativa e positiva -
PANSS e seu uso no Brasil. Rev Psiquiatr Clin (Sa˜o Paulo).
1998;25:337-43.
6 Vessoni ALN. Adaptac¸a˜o e estudo da confiabilidade da escala de
avaliac¸a˜o das sı´ndromes positiva e negativa para a esquizofrenia no
Brasil. Sa˜o Paulo: Universidade Federal de Sa˜o Paulo; 1993.
7 Fresan A, De la Fuente-Sandoval C, Loyzaga C, Garcia-Anaya M,
Meyenberg N, Nicolini H, et al. A forced five-dimensional factor
analysis and concurrent validity of the Positive and Negative
Syndrome Scale in Mexican schizophrenic patients. Schizophr
Res. 2005;72:123-9.
8 Levine SZ, Rabinowitz J. Revisiting the 5 dimensions of the positive and
negative syndrome scale. J Clin Psychopharmacol. 2007;27:431-6.
9 Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr
Bull. 1990;16:537-45.
10 Emsley R1, Rabinowitz J, Torreman M, RIS-INT-35 Early Psychosis
Global Working Group. The factor structure for the Positive and
Negative Syndrome Scale (PANSS) in recent-onset psychosis.
Schizophr Res. 2003;61:47-57.
11 Jiang J, Sim K, Lee J. Validated five-factor model of positive and
negative syndrome scale for schizophrenia in Chinese population.
Schizophr Res. 2013;143:38-43.
12 Van den Oord EJ, Rujescu D, Robles JR, Giegling I, Birrell C,
Bukszar J, et al. Factor structure and external validity of the PANSS
revisited. Schizophr Res. 2006;82:213-23.
13 Kim JH, Kim SY, Lee J, Oh KJ, Kim YB, Cho ZH. Evaluation of the
factor structure of symptoms in patients with schizophrenia.
Psychiatry Res. 2012;197:285-9.
14 Honer WG, Kopala LC, Rabinowitz J. Extrapyramidal symptoms
and signs in first-episode, antipsychotic exposed and non-exposed
patients with schizophrenia or related psychotic illness. J Psy-
chopharmacol. 2005;19:277-85.
15 PappaS,DazzanP.Spontaneousmovementdisorders in antipsychotic-
naive patients with first-episode psychoses: a systematic review.
Psychol Med. 2009;39:1065-76.
Factor structure of the PANSS in Brazil 339
Rev Bras Psiquiatr. 2014;36(4)
